MIA podcast

Kermit Cole tells of his experiences of supporting those in extreme states and his thoughts on Open Dialogue and dialogical approaches in general.

An interview with psychiatrist, academic and author Dr Joanna Moncrieff, one of the founding members of the Critical Psychiatry Network. We talk about the recent meta-analysis of the efficacy and tolerability of 21 antidepressant drugs, widely reported in the UK news media on February 22nd.

Psychiatrist Jim van Os is Chairman of the Department of Psychiatry and Psychology at Maastricht University Medical Centre, Maastricht, The Netherlands. He challenges current diagnostic conceptions of schizophrenia and other mental disorders, and offers a vision for creating a new paradigm of mental health care.

This week on the Mad in America Podcast we launch our series on forced treatment, interviewing antipsychiatry scholar Bonnie Burstow and neurodiversity scholar Nick Walker. Central to both Nick and Bonnie’s work is the concept of cognitive liberty, or freedom and integrity of the mind.

An interview with Sir Robin Murray, who is a Professor of Psychiatric Research at the Institute of Psychiatry. He is perhaps best known for helping to establish the neurodevelopmental hypothesis of schizophrenia, and for his work on the environmental risk factors relating to schizophrenia.

An interview with Tina Minkowitz, attorney and survivor of psychiatry who represented the World Network for Users and Survivors of Psychiatry in the drafting and negotiation of the United Nations’ Convention on the Rights of Persons with Disabilities.

This week on MIA Radio, we interview Chris Hansen. Chris works as Director for Intentional Peer Support and in this interview, we talk about Chris’s personal experiences of the mental health system and how Intentional Peer Support approaches contrast with mainstream psychiatry.

This week we interview psychology graduate and teacher David Mielke who has become increasingly concerned about the number of children in the education system that have a psychiatric diagnosis and are on psychiatric drugs.

An interview with Celia Brown, psychiatric survivor and prominent leader in the movement for human rights in mental health. Celia is the current president of MindFreedom International, and was last year’s recipient of the Lifetime Achievement Award at the Alternatives Conference.

An interview with Dr. David Healy, internationally respected psychiatrist, psychopharmacologist, scientist, and author, discussing Post SSRI Sexual Dysfunction (PSSD) and his innovative approach to finding a cure.

A special two-part interview to join in with events for World Benzodiazepine Awareness Day 2018. We hear from W-BAD Lead Operations Volunteer Nicole Lamberson, psychiatrist Dr Josef Witt-Doerring, therapist and campaigner Chris Paige and Mad in America founder Robert Whitaker.

Dr. Joseph Firth of Western Sydney University talks about his research into the role of exercise and nutrition in supporting young people in the early stages of psychotic illness.

Dr. Rani Bora is a qualified Psychiatrist and Mental Health and Resilience Coach who has studied traditional and alternative approaches to mental well-being, she focuses on holistic ways of supporting people with their mental wellness.

Dr Beggin tells us about recent developments with the Michelle Carter trial, and we discuss alternatives to psychiatric drugs and the value of the therapeutic relationship.

This week on the Mad in America podcast we interview Olga Runciman. Olga is an international trainer and speaker, writer, campaigner, and artist. In this interview, we discuss Olga’s professional and personal experiences of the psychiatric system and how she now helps and supports healing and recovery in others.

An interview with Dr. Duncan Double, consultant psychiatrist in the UK. Duncan is a founder of the Critical Psychiatry Network and runs a critical psychiatry blog. We talk about Duncan’s experiences as a critical psychiatrist working within a bio-medically oriented profession.

An interview with Kelli Foulkrod, who has been integrating yoga and the healing arts into traditional psychotherapy for over eight years and is passionate about offering holistic mental health treatment options.  

An interview with Dr. Lucy Johnstone about the new Power Threat Meaning Framework, an ambitious attempt to outline a conceptual alternative to psychiatric diagnosis which was published on January 12th this year by the Division of Clinical Psychology of the British Psychological Society.

Jim Gottstein, president and founder of the organisation Law Project for Psychiatric Rights, talks about his own experiences with the psychiatric system, patient rights in mental healthcare and the recent trial between Wendy Dolin and the UK Pharmaceutical manufacturer GlaxoSmithKline.

Dr Jay Joseph discusses the evidence that psychiatry puts forward in support of the claim that mental disorders have an important genetic basis and the reasons why psychiatry is still searching after many decades of failed attempts.

Professor Michael O'Loughlin of Adelphi University talks about his childhood experiences and how they influenced his narrative and conversational approaches to supporting those suffering with psychological distress.

An interview with Dr Peter Gordon who describes himself as a gardener with an interest in medicine. He trained in both medicine and architecture before specialising in psychiatry. In addition, he is an activist and campaigner and has a range of creative interests including filmmaking, photography, writing and poetry.

An interview with Professor Sami Timimi and Professor John Read who provide an update on a complaint made to the UK Royal College of Psychiatrists by a group of thirty academics, psychiatrists and people with lived experience.

An interview with Dr. Russell Razzaque, consultant psychiatrist and associate medical director in east London who, together with colleagues, is leading a pioneering multi-centre Open Dialogue pilot in the UK National Health Service.

World Benzodiazepine Awareness Day seeks to raise global awareness of iatrogenic benzodiazepine dependence, the dangers of its adverse effects and the associated withdrawal syndrome, which can last for years.